GC×GC Detective Stories: Biomarkers, Biofuels, and Shape-Shifting Molecules - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

GC×GC Detective Stories: Biomarkers, Biofuels, and Shape-Shifting Molecules

  • By

  • James Strachan

  • Frank van Geel

  • October 1, 2026

  • 15 min

Share

Clinical Report: GC×GC Detective Stories: Biomarkers, Biofuels, and Shape-Shifting Molecules

Background

The identification of biomarkers for inborn errors of metabolism (IEMs) is crucial for early diagnosis and treatment. Traditional analytical methods often struggle with complex biological matrices, making it difficult to detect specific metabolites. The evolution of analytical techniques, particularly GC×GC, offers enhanced resolution and sensitivity, which is essential for accurate biomarker discovery.

Data Highlights

No numerical data or trial results were provided in the source material.

Key Findings

  • GC×GC-TOFMS successfully identified crotonylglycine as a novel urinary biomarker for HMGCS2 deficiency.
  • The biomarker was previously undetectable using one-dimensional GC-MS due to coelution with adipic acid.
  • Inborn errors of metabolism often result in the accumulation of metabolites that can be detected in urine.
  • GC-MS remains the reference technique for urinary organic acid analysis due to its ability to handle small, diverse organic acids.
  • LC-MS/MS is also used in metabolic laboratories, but it has limitations compared to GC-MS.

Clinical Implications

The use of GC×GC can significantly improve the detection of specific biomarkers in newborn screening, potentially leading to earlier diagnosis of metabolic disorders. This advancement underscores the importance of utilizing advanced analytical techniques in clinical laboratories to enhance diagnostic accuracy.

Conclusion

The application of GC×GC in identifying hidden biomarkers represents a significant advancement in the field of metabolic disorder diagnostics. This technique provides a valuable tool for researchers and clinicians in the ongoing effort to improve newborn screening outcomes.

Related Resources & Content

  1. Marriott P, Webster R, Kouremenos K, The Analytical Scientist, 2026 -- GC×GC Detective Stories: Biomarkers, Biofuels, and Shape-Shifting Molecules
  2. the analytical scientist — GCxGC Detective Stories: Follow Your Nose
  3. the analytical scientist — GCxGC Detective Stories: The Smell of Adventure
  4. the analytical scientist — GCxGC Detective Stories: Not Just a Pretty Face
  5. Recommended Uniform Screening Panel | Newborn Screening
  6. Classic Isovaleric Acidemia - GeneReviews® - NCBI Bookshelf
  7. Evidence Regarding Duchenne Muscular Dystrophy Newborn Screening | Pediatrics | American Academy of Pediatrics

Original Source(s)

Related Content